Health Condition 1: K929- Disease of digestive system, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
Jyoti Garg
Eligibility
Inclusion criteria
Inclusion criteria: Those who are aged 18 years or above will be included. Low and Normal BMI patients and Patient receiving only Iohexol contrast of concentration 300 mgI/ml
Exclusion criteria
Exclusion criteria: Trauma & Emergency cases Patients with conditions such as liver cirrhosis, severe fatty liver, as assessed through USG reports, which can change the density of the organs. Pathologies such as hepatocellular carcinoma (HCC) requiring higher contrast volumes. Patients with an allergy to iodinated contrast Patients with High creatinine level Patients with high BMI
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| To develop an optimized contrast dosing protocol based on the most predictive body size parameter and compare liver enhancement and image quality before and after optimization.Timepoint: 1.5 years | — |
Primary
| Measure | Time frame |
|---|---|
| To assess the correlation between body size parameters (TBW, LBW, BSA, FFM, AFR) and hepatic enhancement, and to evaluate image quality (quantitative and qualitative) in low- and normal-BMI groups at 80 and 100 kVp.Timepoint: 1.5 years | — |
Countries
India
Contacts
Public ContactDr Nitika C Panakkal
Manipal College of Health Professions (MCHP), MAHE
Outcome results
None listed